Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab-Reference-Cited by-同舟云学术

Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab

Published:2022-07-01 Issue:7 Volume:158 Page:762
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Enevold Christian¹,Loft Nikolai²³,Bregnhøj Anne⁴⁵,Zachariae Claus²³⁶,Iversen Lars⁴⁵,Skov Lone²³⁶,Nielsen Claus Henrik¹

Affiliation:

1. Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

2. Department of Dermatology and Allergy, Copenhagen University Hospital–Herlev and Gentofte, Copenhagen, Denmark

3. Copenhagen Research Group for Inflammatory Skin, Copenhagen University Hospital–Herlev and Gentofte, Copenhagen, Denmark

4. Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark

5. Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark

6. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2792712/jamadermatology_enevold_2022_oi_220024_1657583965.96525.pdf

Reference28 articles.

1. Pathophysiology, clinical presentation, and treatment of psoriasis: a review.;Armstrong;JAMA,2020

2. Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody.;Russell;J Immunol,2014

3. Structure and signalling in the IL-17 receptor family.;Gaffen;Nat Rev Immunol,2009

4. IL-17C/IL-17RE: emergence of a unique axis in TH17 biology.;Nies;Front Immunol,2020

5. Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis.;Egeberg;J Eur Acad Dermatol Venereol,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral CD4+ T helper lymphocytes alterations in major depressive disorder: A systematic review and meta-analysis;Neuroscience;2024-09

2. Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis;JAMA Dermatology;2024-08-01

3. Ixekizumab trough concentrations in psoriasis: Paving the way towards personalised therapy: A cohort study;JEADV Clinical Practice;2024-07-04

4. The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-05-26

5. Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis;Journal of the European Academy of Dermatology and Venereology;2024-05-08